Wenjin Yin

This study is testing a drug called trastuzumab deruxtecan in 118 adults with advanced breast cancer. The goal is to see how long the drug can keep the cancer from growing and what side effects occur. Participants must be in good overall health (ECOG 0-1) and not pregnant or nurs…

This study compares two ways of taking the drug pyrotinib for people with HER2-positive advanced breast cancer: taking it every day (continuous) or taking breaks (intermittent). The goal is to see which schedule works better and has fewer side effects. About 186 adults whose canc…

This study tests a new drug called QL1706 in people with a common type of advanced breast cancer (HR+/HER2-). The goal is to see if it can slow down the cancer's growth and check for side effects. About 123 women will take part, and the results will be compared to standard care.

This study is looking at whether taking a CDK4/6 inhibitor (either abemaciclib or ribociclib) after surgery can help prevent breast cancer from coming back in people with HR+/HER2- breast cancer. The researchers will follow 229 participants to see how long they stay cancer-free a…

This study compares a combination of two chemotherapy pills (capecitabine and cyclophosphamide) against standard maintenance treatments for women with advanced breast cancer whose disease is under control after initial therapy. The goal is to see which approach better delays canc…